Metropolregion Basel
Kontaktinformationen
96.475 Follower:innen
500+ Kontakte
Info
Artikel von Frank Kumli
-
The Future of Generative AI in Pharma: Four Scenarios!
The Future of Generative AI in Pharma: Four Scenarios!
Von Frank Kumli
-
Startups as Enablers of Healthcare Innovation and Economic Growth!
Startups as Enablers of Healthcare Innovation and Economic Growth!
Von Frank Kumli
Beiträge
Aktivitäten
-
Energie doppelt genutzt - das ist uptownBasel von Fankhauser Arealentwicklung
Energie doppelt genutzt - das ist uptownBasel von Fankhauser Arealentwicklung
Beliebt bei Frank Kumli
-
La Suisse, quelles que soient les comparaisons internationales (WEF, IMD, UIT...), se retrouve toujours dans le peloton de tête des nations…
La Suisse, quelles que soient les comparaisons internationales (WEF, IMD, UIT...), se retrouve toujours dans le peloton de tête des nations…
Beliebt bei Frank Kumli
-
You're not prepared for the impact of the EU AI Act on healthcare. And you have two years to get on track. With many AI systems in healthcare…
You're not prepared for the impact of the EU AI Act on healthcare. And you have two years to get on track. With many AI systems in healthcare…
Beliebt bei Frank Kumli
Berufserfahrung und Ausbildung
-
Self-Employed
Gesamte Berufserfahrung von Frank Kumli anzeigen
Wenn Sie auf „Weiter“ klicken, um Mitglied zu werden oder sich einzuloggen, stimmen Sie der Nutzervereinbarung, der Datenschutzrichtlinie und der Cookie-Richtlinie von LinkedIn zu.
Bescheinigungen und Zertifikate
Veröffentlichungen
-
The rise of digital healthcare – fuelled by open innovation in healthtech hubs
pmlive
Veröffentlichung anzeigenHow the ever-increasing uptake of digital solutions is enhancing patient engagement, increasing access to care and lowering the cost of drug development
-
Shifting the pain management paradigm
International Hospital & Equipment
Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not managed correctly. Alarmingly, chronic pain affects more than 30 percent of people worldwide, [1] yet current treatments can be ineffective or lead to drug dependence, leaving many individuals in dire need of innovative solutions that will help them find relief. In response, researchers are exploring ground-breaking ways to manage pain – from neuroplasticity training through…
Pain is a crucial sensation for survival, but it can also drive us to depression and long-term suffering if not managed correctly. Alarmingly, chronic pain affects more than 30 percent of people worldwide, [1] yet current treatments can be ineffective or lead to drug dependence, leaving many individuals in dire need of innovative solutions that will help them find relief. In response, researchers are exploring ground-breaking ways to manage pain – from neuroplasticity training through interactive games to therapies that use virtual reality (VR) – which promise to shake up the status quo of clinical pain management in the years to come. In fact, these fascinating approaches are already finding their place in forward-thinking healthcare institutions, supported by the healthtech sector, which is booming in multiple locations around Europe, especially in the Basel area in Switzerland.
Andere Autor:innen -
-
Swiss medtech – bringing together traditional skills and high-tech industry
med-technews
Veröffentlichung anzeigenThe canton of Jura is successfully expanding its global reputation for watchmaking capabilities to also become a big name in the medtech circle, attracting a wide range of start-ups such as CNS Therapy, Incaptek and CryoThermo. These budding companies are receiving support from both watchmaking veterans and incubators, fuelling innovations in medical devices. InnoSpina – a company specialising in innovative instruments for spinal fusion and motion preserving surgeries – is one of the many…
The canton of Jura is successfully expanding its global reputation for watchmaking capabilities to also become a big name in the medtech circle, attracting a wide range of start-ups such as CNS Therapy, Incaptek and CryoThermo. These budding companies are receiving support from both watchmaking veterans and incubators, fuelling innovations in medical devices. InnoSpina – a company specialising in innovative instruments for spinal fusion and motion preserving surgeries – is one of the many businesses that have sprung up in the Jura, benefiting from the collaborative spirit and local talent that this region has to offer.
-
How digital transformation is driving pharmaceutical innovation in Basel
Innovations in Pharmaceutical Technology
Veröffentlichung anzeigenigital technologies – such as artificial intelligence (AI), natural language processing and data analytics – are revolutionising healthcare by helping medical professionals to make better, more informed decisions, as well as by accelerating the discovery of new therapies.
These advancements promise to propel healthcare into the future and make the seemingly impossible possible, including everything from optimising patient care through robust data analytics, to aiding the discovery of…igital technologies – such as artificial intelligence (AI), natural language processing and data analytics – are revolutionising healthcare by helping medical professionals to make better, more informed decisions, as well as by accelerating the discovery of new therapies.
These advancements promise to propel healthcare into the future and make the seemingly impossible possible, including everything from optimising patient care through robust data analytics, to aiding the discovery of complex disease patterns through AI algorithms. This article features some examples of digital technology, which are supporting pharmaceutical R&D in the innovative science hub that is the Basel area, Switzerland, and describes how these latest developments will play a major role in the ever-changing healthcare landscape. -
Progressions BioPharma 4.0: platform models to capture value
EY
As health care delivery expands beyond the physician’s office, the hospital or the laboratory, and as therapeutic solutions broaden beyond the pill, a platform-based health care economy is emerging. Platforms are marketplaces that allow consumers to connect easily with supplies of products, services or solutions that are tailored to their needs. These are the Amazons or Alibabas of health care: flexible, scalable interfaces that create communities of connected users, underpinned by multiple…
As health care delivery expands beyond the physician’s office, the hospital or the laboratory, and as therapeutic solutions broaden beyond the pill, a platform-based health care economy is emerging. Platforms are marketplaces that allow consumers to connect easily with supplies of products, services or solutions that are tailored to their needs. These are the Amazons or Alibabas of health care: flexible, scalable interfaces that create communities of connected users, underpinned by multiple suppliers and partners.
Andere Autor:innen -
-
Connecting the Data Dots
MedicalExpo e-magazine
Veröffentlichung anzeigenEnhanced connectivity can drive a transformational shift in the way laboratories operate and add value in many areas. The fragmented and standalone nature of laboratory devices is both a problem and opportunity that needs to addressed now.
-
Better with age - the silver economy opportunity
EY
Our article “Better with age,” that we have co-authored with Stephan Ohnmacht and Patrick Flochel in the March 2017 edition of the EY Life Sciences Report: Asia, provides a more in-depth analysis of the aging society and the need for pharmaceutical professionals to be competitive and to adapt to the ever-changing commercial and regulatory environment. Check it out on pages 16 to 21 of the report.
Andere Autor:innen -
-
Dr. med. Ap: Die digitale Transformation macht auch vor den Life Sciences nicht halt
Neue Zürcher Zeitung
Die Zukunft gehört den daten- getriebenen Therapieformen. Der Standort Basel nimmt die Herausforderung an und investiert in die sogenannte Precision Medicine
Andere Autor:innen -
-
Multichannel is about customer experience. We've got that! Now what?
Performance
The best companies obsess over solving their customers’ biggest problems first, knowing that, if they do, the relationship will be secure. It’s time to engage customers beyond the simple provision or exchange of information. The competitive environment, in many industries, has moved toward value-adding services that allow these companies either to differentiate from the competition or, even, to create completely new markets.
The article examines the three strategic options that life…The best companies obsess over solving their customers’ biggest problems first, knowing that, if they do, the relationship will be secure. It’s time to engage customers beyond the simple provision or exchange of information. The competitive environment, in many industries, has moved toward value-adding services that allow these companies either to differentiate from the competition or, even, to create completely new markets.
The article examines the three strategic options that life sciences can take to customer engagement design and experience.Andere Autor:innen -
-
Embracing customer experience in the pharmaceutical industry
Performance
In our rapidly evolving society, it is becoming the norm for customers to make their decision on whether they buy a product based on their overall experience in dealing with a brand or company.
The pharmaceutical business environment is complex, science-driven and regulated. While purchasing (or prescribing) decisions in this environment are not solely driven by personal preference, the industry is not immune to this transformation. Its customers are becoming resistant to push sales and…In our rapidly evolving society, it is becoming the norm for customers to make their decision on whether they buy a product based on their overall experience in dealing with a brand or company.
The pharmaceutical business environment is complex, science-driven and regulated. While purchasing (or prescribing) decisions in this environment are not solely driven by personal preference, the industry is not immune to this transformation. Its customers are becoming resistant to push sales and marketing, and are instead preferring to relate to the overall experience provided in their pull interactions with the company.
Customer experience will be the next battleground for the pharmaceutical industry and, in this article, we explore what it means for the sector.Andere Autor:innen -
-
Healthcare 4.0
Handelskammer Beider Basel
Das Gesundheitswesen wird in den nächsten fünf bis zehn Jahren einen grundlegenden Wandel erfahren. Big Data eröffnet neue Möglichkeiten für Patienten und Leistungserbringer. Was bringen diese Veränderungen konkret mit sich?
Andere Autor:innen -
-
18 Experts Predict How Technology Will Transform Healthcare
URIKA
Veröffentlichung anzeigenIn recent decades, technology has skyrocketed in terms of advancement and new treatments, instruments and discoveries are brought forward almost every day. But this is still the very beginning – who knows what lies ahead and what this will mean for our medical future? We’ve gathered 18 healthcare and medical experts from around the world who have shared their input as to how technology will further evolve and advance the healthcare industry in the future.
-
Is your multichannel strategy having the desired impact on both your customer and business?
PMLive.com
The critical role of multichannel in delivering a differentiated customer experience and tangible business results.
Andere Autor:innen -
-
Operation Big Data
Handelszeitung
Die digitale Transformation wird die Industrie auf den Kopf stellen. Konzerne wie Novartis und Roche müssen die Weichen stellen.
-
The new EU Medical Device Regulation
EY
Veröffentlichung anzeigenA whole-of-business approach
Even with a three-year window, regulatory teams will not be able to complete all this work in isolation. It is evident that compliance with the EU MDR requires an approach that takes in all aspects of the business. For the regulatory teams into whose laps this has fallen, this represents a separate challenge: how to engage senior leadership to understand the importance of the task ahead and commit resources to tackle it?
Regulatory teams that successfully…A whole-of-business approach
Even with a three-year window, regulatory teams will not be able to complete all this work in isolation. It is evident that compliance with the EU MDR requires an approach that takes in all aspects of the business. For the regulatory teams into whose laps this has fallen, this represents a separate challenge: how to engage senior leadership to understand the importance of the task ahead and commit resources to tackle it?
Regulatory teams that successfully convinced the C-suite of the need for firmwide action on the EU MDR have learned that the crucial element in the conversation is to look beyond compliance and link it to their firm’s leadership agenda: emphasize the EU MDR’s impact on top-line revenue and profitability, M&A opportunities, or operations, and present best-case and worst-case scenarios. -
Commercial Excellence in Pharma 3.0
EY
Veröffentlichung anzeigenPharmaceutical companies are being challenged to adapt their commercial models to offer individualized value propositions increasingly centered on delivering health outcomes. To achieve commercial excellence in this environment will require insight — insight into value requirements and insight into what it is that determines and drives certain behavior. It also depends on the ability of an organization to collect, assess and reflect market learning, in real time.
-
Meeting the digital challenge in life sciences
EY
Only by taking the risk of engaging online can companies reap the rewards – becoming a trusted partner in the health care journey of patients and other stakeholders.
Andere Autor:innen -
-
Pharma 3.0: l'engagement du système de santé pour obtenir de meilleurs résultats
Agefi
Engager, collaborer et gérer les différents acteurs de cet écosystème constitue la formule du succès du modèle Pharma 3.0 mais également le principal défi, notamment quant il s’agit des perceptions de conflits d’intérêts et de mercantilisme pesant de plus en plus lourdement sur l’industrie. Ces perspectives doivent être traitées en amont.
Andere Autor:innen -
-
Pharma 3.0: delivering on health outcomes
Journal of Business Chemistry
Beyond the short-term cost-cutting initiatives that the pharmaceutical industry is navigating with diversification strategies, the opportunity is clear for the industry to become more visible in demonstrating the value it brings to the health care system.
Andere Autor:innen -
-
Vorstoss in unbekannte Gewässer
NZZ
Die rasanten informationstechnischen Entwicklungen im Gesundheitsbereich ermöglichen und fördern ein ergebnisorientiertes Vorgehen. Die Digitalisierung von Gesundheitsdaten, elektronische Patientendossiers und die damit verbundenen E-Health-Plattformen versprechen zunehmende Sicherheit und Effizienz beim Erbringen von Gesundheitsdienstleistungen.
Andere Autor:innen -
-
Pharmaindustrie: Auf dem Weg zu neuen Geschäftsmodellen
EY
Entscheidend für den Geschäfterfolg eines Pharmaunternehmens ist nicht mehr nur die Produktpipeline, sondern das gesamte Geschäftsmodell. Ein Unternehmen muss somit in der Lage sein, Geschäftschancen zu erkennen, auszuschöpfen und die damit verbundenen Risiken zu steuern. Die Fähigkeit zur Implementierung neuer Strategien und innovativer Geschäftsmodelle erfordert deutlich verbesserte Unternehmensfunktionen.
Andere Autor:innen -
-
Welcome to Pharma 3.0
chemanager
In the end, the winners in the Pharma 3.0 world will look beyond themselves and beyond the question, "What are we inventing?" to "What are others doing, how can we leverage their strengths for collaborative advantage and how can we fit into their business models?"
The end point will be an "outside-in" way of innovating - one that can continuously deliver on the promise of sustained value creation.Andere Autor:innen -
-
Les pharmas doivent penser «services»
Le Temps
Veröffentlichung anzeigenEt si Novartis s’alliait à Google afin de devenir leader dans le suivi informatique de ses patients consommateurs pour leur offrir des médicaments parfaitement adaptés à leur situation?
-
The Science of Alliance Funding
Pharmaceutical Licensing: Deal Sourcing & Metrics
The article provides an overview of the partnering activities within the industry and the trend towards a collaborative approach to developing mutual arrangement between companies. It also notes the factors driving the convergence of industry alliances such as cultural change, technological capabilities, and deal market potential.
Andere Autor:innen -
Patente
-
Mercapto-alkanol flavor compounds
Ausgestellt am US 6805893
New diastereoisomer-enriched 3-mercapto-alkanols are disclosed. The compounds, namely 3-mercapto-2-methyl-butan-1-ol and/or 3-mercapto-3-methyl-hexan-1-ol, and the stereoisomers of each, are used to flavor products, such as foods and/or beverages.
Andere Erfinder:innen -
-
Serine carbonates
Ausgestellt am US 10/219,964
Serine carbonates of formula I are precursors for organoleptic compounds, masking agents and antimicrobial agents. Further they are alternative substrates for malodor producing enzymes.
Andere Erfinder:innen -
-
Compounds having protected hydroxy groups
Ausgestellt am US 9/685,446
The present invention relates to compounds with protected hydroxy groups of formula (I)
Andere Erfinder:innen -
Projekte
-
Identify and Evaluate Promising Business Opportunities “Beyond the Pill” Quickly and Efficiently
Andere Mitarbeiter:innen -
Sprachen
-
English
-
-
French
-
-
German
-
Erhaltene Empfehlungen
3 Personen haben Frank Kumli empfohlen
Jetzt anmelden und ansehenWeitere Aktivitäten von Frank Kumli
-
Mission-Oriented Industrial Strategy! 1. Challenges The challenges worldwide are clear: global warming, weak health systems, the digital divide and…
Mission-Oriented Industrial Strategy! 1. Challenges The challenges worldwide are clear: global warming, weak health systems, the digital divide and…
Beliebt bei Frank Kumli
-
Mission-Oriented Industrial Strategy! 1. Challenges The challenges worldwide are clear: global warming, weak health systems, the digital divide and…
Mission-Oriented Industrial Strategy! 1. Challenges The challenges worldwide are clear: global warming, weak health systems, the digital divide and…
Geteilt von Frank Kumli
-
Tempus AI went public one month ago and has maintained its $37 stock price so far, resulting in a $6 billion valuation. Before Tempus, most…
Tempus AI went public one month ago and has maintained its $37 stock price so far, resulting in a $6 billion valuation. Before Tempus, most…
Beliebt bei Frank Kumli
-
Entdecken Sie das Porträt von Vincent Zoete, dem Tumor-Hacker! 👨💻💉🧫 Der Bioinformatiker entwickelt am Universitätsspital Lausanne und am Swiss…
Entdecken Sie das Porträt von Vincent Zoete, dem Tumor-Hacker! 👨💻💉🧫 Der Bioinformatiker entwickelt am Universitätsspital Lausanne und am Swiss…
Beliebt bei Frank Kumli
-
**DECISION DESIGN – Frictions in Desirability (#GG 7)** "Only mankind knows catastrophe, to the extent we survive it. Nature does not know…
**DECISION DESIGN – Frictions in Desirability (#GG 7)** "Only mankind knows catastrophe, to the extent we survive it. Nature does not know…
Beliebt bei Frank Kumli
-
Why consumers use other methods alongside #GLP-1 for #weight management? 👇 The answers underline the huge potential of #digitalhealth and…
Why consumers use other methods alongside #GLP-1 for #weight management? 👇 The answers underline the huge potential of #digitalhealth and…
Beliebt bei Frank Kumli
Weitere ähnliche Profile
Weitere Beiträge entdecken
Weitere Mitglieder, die Frank Kumli heißen
Es gibt auf LinkedIn 1 weitere Person, die Frank Kumli heißt.
Weitere Mitglieder anzeigen, die Frank Kumli heißen